
Kripime T 1000mg/125mg Injection
Marketer
Kritikos Care
Salt Composition
Cefepime (1000mg) + Tazobactum (125mg)
Overview Kripime T 1000mg/125mg Injection
The antibiotic combination injection, Kripime T (1000mg/125mg), combats bacterial infections by inhibiting microbial proliferation. Administered only by a healthcare provider, this medication requires adherence to the prescribed schedule; completing the entire course is crucial, even with symptom improvement. Potential side effects include gastrointestinal upset (nausea, vomiting, diarrhea), skin rashes, and localized injection site reactions (redness, swelling, pain), typically resolving spontaneously. Severe side effects or allergic responses (rash, itching, swelling, respiratory distress) necessitate immediate medical attention. Prior to use, disclose all current medications and health conditions to your physician, including pregnancy or breastfeeding status. Alcohol consumption should be avoided due to the risk of increased drowsiness. While generally not impairing driving ability, refrain from driving if drowsiness or dizziness occurs.
Uses of Kripime T 1000mg/125mg Injection
Infections caused by bacteria
Major Benefits of Kripime T 1000mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Kripime T 1000mg/125mg Injection:
- Diarrhea
- Increased white blood cell count (eosinophils)
- Injection site phlebitis
- Skin rash
- Increased liver enzymes
- Positive Coombs test
How to use Kripime T 1000mg/125mg Injection:
This medication will be administered by your healthcare provider; please do not attempt self-medication.
How Kripime T 1000mg/125mg Injection works:
Kripime T Injection (1000mg cefepime/125mg tazobactam) combines a cephalosporin antibiotic, cefepime, with a beta-lactamase inhibitor, tazobactam. Cefepime's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Tazobactam counteracts bacterial enzymes (beta-lactamases) that would otherwise inactivate cefepime. This synergistic effect broadens cefepime's antibacterial spectrum and overcomes resistance mechanisms.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Kripime T 1000mg/125mg Injection alongside alcohol. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The injectable medication Kripime T (1000mg/125mg) is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no harmful consequences to the fetus; nevertheless, clinical data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Kripime T 1000mg/125mg Injection poses no known breastfeeding safety risk. Research in humans indicates minimal drug transfer to breast milk, presenting negligible harm to the infant.
DrivingUNSAFE
Following administration of Kripime T 1000mg/125mg Injection, temporary blurred vision may occur. Refrain from driving until visual acuity returns to normal.
KidneyCAUTION
Administering Kripime T 1000mg/125mg Injection requires careful consideration in individuals with impaired renal function. Dosage modification for Kripime T 1000mg/125mg Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Kripime T 1000mg/125mg Injection appears to pose minimal risk for individuals with hepatic impairment. Existing evidence indicates dose modification may be unnecessary for this patient group. However, physician consultation is recommended.
What if you forget to take Kripime T 1000mg/125mg Injection :
Omitting a scheduled dose of Kripime T 1000mg/125mg Injection necessitates contacting your physician.
Facts to Know About Kripime T 1000mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
